Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thermomechanical Stimulation for Pain in Nail Injection
NCT04422795Phase 4Withdrawn
- Sponsor
- Weill Cornell Medicine
- Start
- Feb 2024
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (3 arms), sponsored by Weill Cornell Medicine. Primary endpoint: Level of pain and change in pain. Planned start Feb 2024; status: withdrawn.
Beyond the preview
Go deeper on NCT04422795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04422795.